HCV-NUKLEOSIDINHIBITOR

Patent europeic · EP2084175 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2084175
Numer da la dumonda
EP07820934
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
04-10-2007
Publitgà
05-08-2009
Concedì
29-12-2010
Stritgà
31-10-2018
Motiv
Taxa annuala betg pajada
Classas IPC
C07H 19/073 (2006.01)
A61K 31/513 (2006.01)
A61P 31/12 (2006.01)
Prioritad
US 850926 P 10.10.2006
Dumonda PCT
PCT/EP2007/060557 04.10.2007
Publicaziun PCT
WO2008/043704 17.04.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-05-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 22.05.2019

  2. 10-09-2013

    Transferì

    Owner
    Medivir AB, P.O. Box 1086, 141 22 Huddinge, Sweden → Medivir AB, P.O. Box 1086, 141 22 Huddinge, Sweden, Janssen Products, LP, 800/850 Ridgeview Drive, Horsham, PA 19044, USA

    Published in Swissreg on 10.09.2013

  3. 04-05-2011

    Represchentant inscrit

    Representative
    Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano

    Published in Swissreg on 04.05.2011

  4. 29-12-2010

    Concedì

    Published in Swissreg on 29.12.2010

Partidas

Inventur

JOHANSSON, Nils-Gunnar

14144 Huddinge, SE

KALAYANOV, Genadiy

14144 Huddinge, SE

MARTIN, Joseph Armstrong

Harpenden Hertfordshire AL5 2BN, GB

SMITH, David Bernard

San Mateo, CA 94403, US

WINQVIST, Anna

14144 Huddinge, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.